Diebold Nixdorf, Incorporated Stock Price and Value Analysis

Should you buy Diebold Nixdorf, Incorporated stock? (NYSE:DBD). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company is less known than others.
  • This company pays no dividend.

Inside the DBD Numbers

DBD Price
(Diebold Nixdorf, Incorporated stock price per share)
$8.76
[?] PE Ratio versus Sector 57% higher than other Technology stocks
[?] PE Ratio versus Industry 96% higher than other Unknown stocks
[?] Cash Yield 7.07%
[?] Free Cash Flow Jitter 160%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 6,818,198 shares shorted. With 67,989,949 shares available for purchase and an average trading volume over the past 10 trading days of 780,250, it would take at least 8.738 days for all of the short holders to cover their shorts.

Is Diebold Nixdorf, Incorporated Stock on Sale?

Based on our analysis, we believe that you should not buy Diebold Nixdorf, Incorporated right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy DBD Stock?

Does Diebold Nixdorf, Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.